Eating Disorder Examination: Deutschsprachige Version des strukturierten Essstörungsinterviews

Diagnostica ◽  
2004 ◽  
Vol 50 (2) ◽  
pp. 98-106 ◽  
Author(s):  
Anja Hilbert ◽  
Brunna Tuschen-Caffier ◽  
Martina Ohms

Zusammenfassung. Das Eating Disorder Examination (EDE) von Fairburn und Cooper (1993) ist ein strukturiertes Essstörungsinterview zur Erfassung der spezifischen Psychopathologie von Essstörungen. In der klinischen Forschung und Praxis gilt es weithin als Methode der Wahl für die Essstörungsdiagnostik. Die in diesem Beitrag vorgestellte deutschsprachige, reübersetzte Version des EDE zeigte in Stichproben von 80 Patientinnen mit Bulimia Nervosa, 144 Patientinnen mit Binge-Eating-Störung und 20 Patientinnen mit Anorexia Nervosa hohe Interrater-Reliabilitäten der Items sowie der Subskalen. Als Indikatoren für die konvergente Validität waren die EDE-Subskalen Shape Concern und Weight Concern mit Selbstbeurteilungsskalen zum Körperbild, z.B. dem Fragebogen zum Figurbewusstsein, hoch korreliert. Die EDE-Subskalen Restraint und Eating Concern zeigten signifikante Zusammenhänge mit dem in Ernährungstagebüchern protokollierten Essverhalten, z.B. Mahlzeiten- oder Essanfallshäufigkeit oder Nährstoffaufnahme. Die Subskalen des EDE unterschieden zwischen Gruppen mit verschiedenen Essstörungsdiagnosen und bildeten Veränderungen durch psychologische Psychotherapie sensitiv ab. Somit steht mit der deutschsprachigen Version des EDE ein dem englischsprachigen Original entsprechendes, geeignetes Instrument für die Erfassung der spezifischen Psychopathologie von Essstörungen zur Verfügung.

1997 ◽  
Vol 31 (4) ◽  
pp. 514-524 ◽  
Author(s):  
Pierre J.V. Beumont ◽  
Janice D. Russell ◽  
Stephen W. Touyz ◽  
Cathy Buckley ◽  
Kitty Lowinger ◽  
...  

Objective: The aims of the paper are to determine whether nutritional counselling is associated with an improvement in bulimic symptomatology, whether this improvement is maintained during post-treatment follow-up, and whether the addition of fluoxetine 3 × 20 mg/day confers additional benefit. Method: Psychological, pharmacological and combined psychopharmacological treatments of bulimia nervosa were reviewed briefly. Sixty-seven patients referred to specialist eating disorder services who fulfilled strict diagnostic criteria were treated with intensive nutritional counselling and randomly assigned to either fluoxetine 3×20 mg/day or placebo. After a 1-week ‘wash-out’, active treatment was given over 8 weeks, followed by post-treatment interviews at 12 and 20 weeks. Results: Both groups of patients improved significantly during treatment. In some respects, the fluoxetine group did slightly better as demonstrated by the items ‘restraint’, ‘weight concern’ and ‘shape concern’ (p<0.05 vs p<0.0001) on the Eating Disorder Examination (EDE). Fluoxetine patients decreased their energy intake and lost a modest amount of weight. They went on to regain weight during the follow-up period, returning to levels higher than they were initially. These patients also appeared more likely to have a recurrence of symptoms, as shown by the fall in percentage of binge-free patients and by changes in the EDE. Conclusion: Nutritional counselling is an effective means of treating bulimia nervosa, with improvement maintained up to 3 months follow-up. The addition of fluoxetine may confer some benefit during active treatment, but its discontinuation may contribute to a higher rate of recurrence of symptoms post treatment. Of course, this study cannot be extrapolated to the efficacy of fluoxetine when used as the only form of treatment in patients for whom intensive nutritional counselling or other structured psychological programs are not available.


2010 ◽  
Vol 39 (4) ◽  
pp. 251-260 ◽  
Author(s):  
Karolin Neubauer ◽  
Caroline Bender ◽  
Brunna Tuschen-Caffier ◽  
Jennifer Svaldi ◽  
Jens Blechert

Zusammenfassung. Theoretischer Hintergrund: Empirische Befunde zeigen, dass körperbezogenes Kontrollverhalten und die zugrunde liegenden Kognitionen eine zentrale Rolle in der Aufrechterhaltung von Essstörungspsychopathologie spielen. Fragestellung: Eine deutschsprachige Version der Body Checking Cognitions Scale (BCCS) soll teststatistisch überprüft werden. Methode: Frauen mit Anorexia Nervosa (n = 19), Bulimia Nervosa (n = 22) und Binge-Eating Störung (n = 28) sowie eine weibliche nicht-klinische Vergleichsgruppe (n = 195) füllten die BCCS sowie weitere Fragebögen zur Essstörungspsychopathologie aus. Ergebnisse: Das 4-Faktorenmodell der englischsprachigen Originalversion zeigte in Faktorenanalysen die beste Passung. Die deutschsprachige BCCS erwies sich als intern konsistent und zeigte eine zufriedenstellende konvergente und diskriminante Validität. Schlussfolgerungen: Die deutschsprachige BCCS ist ein reliabler und valider Selbstbeurteilungsfragebogen. Sie stellt ein vielversprechendes Instrument zum Einsatz in der Essstörungstherapie und -forschung dar.


Author(s):  
Susan McElroy ◽  
Anna I. Guerdjikova ◽  
Nicole Mori ◽  
Paul E. Keck

This chapter addresses the pharmacotherapy of the eating disorders (EDs). Many persons with EDs receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. This chapter first provides a brief rationale for using medications in the treatment of EDs. It then reviews the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES). It concludes by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.


Author(s):  
Susan L. McElroy ◽  
Anna I. Guerdjikova ◽  
Anne M. O’Melia ◽  
Nicole Mori ◽  
Paul E. Keck

Many persons with eating disorders (EDs) receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. In this chapter, we first provide a brief rationale for using medications in the treatment of EDs. We then review the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa, binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES) and sleep-related eating disorder (SRED). We conclude by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.


Author(s):  
Christopher Hübel ◽  
Mohamed Abdulkadir ◽  
Moritz Herle ◽  
Ruth J. F. Loos ◽  
Gerome Breen ◽  
...  

Author(s):  
Marco La Marra ◽  
Walter Sapuppo ◽  
Giorgio Caviglia

The aim of this study has been to investigate the dissociative phenomena and the difficulties related to perceive, understand and describe the proper ones and other people's emotional states in a sample of 53 patients with Eating Disorders. The recruited sample is made by 14 Anorexia Nervosa (AN) patients, 15 with Bulimia Nervosa (BN), 12 with Eating Disorder Non Otherwise Specified (EDNOS) and 12 with Binge Eating Disorder (BED). To all subjects was administred the Eating Disorder Inventory-2, the Dissociative Experiences Scale and the Scala Alessitimica Romana. In according with literature, we confirme the relationships among Eating Disorders, the dissociative phenomena and Alexithymia.


Nutrients ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 2834
Author(s):  
Lisa Brelet ◽  
Valentin Flaudias ◽  
Michel Désert ◽  
Sébastien Guillaume ◽  
Pierre-Michel Llorca ◽  
...  

Research about stigmatization in eating disorders (EDs) has highlighted stereotypes, prejudices, and discrimination against people with EDs, as well as their harmful effects on them, including self-stigma and a difficult recovery process. Whereas a recent review focused on the consequences of ED stigma, our work aimed to provide a broader synthesis of ED stigma, including its consequences, but also its content and distribution. More precisely, we focused on three EDs—namely, anorexia nervosa, bulimia nervosa, and binge eating disorder. Based on a systematic search of four major databases in psychology, the present scoping review includes 46 studies published between 2004 and 2021. We did not conduct any quality assessment of the studies included, because our aim was to provide a wide-ranging overview of these topics instead of an appraisal of evidence answering a precise research question. The review confirmed the existence of a common ED stigma: all individuals affected by EDs reviewed here were perceived as responsible for their situation, and elicited negative emotions and social distance. However, our review also depicted a specific stigma content associated with each ED. In addition, the demographic characteristics of the stigmatizing individuals had a notable influence on the extent of ED stigma: men, young adults, and low-income individuals appeared to be the most stigmatizing toward individuals with EDs. It is important to note that ED stigma had a negative effect on individuals’ eating disorders, psychological wellbeing, and treatment-seeking behavior. There is an urgent need for further research on the adverse effects of ED stigma and its prevention.


Sign in / Sign up

Export Citation Format

Share Document